Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol TIVA for hysteroscopic surgery recovery
ChiCTR2500095274Phase 4Completed
- Sponsor
- The First Affiliated Hospital of the University of South China
- Start
- Jan 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol and propofol in gynaecological conditions (2 arms), sponsored by The First Affiliated Hospital of the University of South China. Primary endpoint: QoR-15 score at 24 hours postoperatively. Started Jan 2025; status: completed.
02
Drugs
ciprofolpropofol
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on ChiCTR2500095274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095274.